vor 5 Jahren

Impfstoff-Studienergebnisse von Biontech/Pfizer in Fachjournal

NEW YORK (dpa-AFX) - Die ersten Ergebnisse der Phase-III-Studie zum Corona-Impfstoff des Mainzer Herstellers BioNTech und seines US-Partners Pfizer sind nun auch im renommierten Fachmagazin "New England Journal of Medicine" veröffentlicht worden. In dem Artikel bekräftigen die beteiligten Wissenschaftler, dass die Wirksamkeit des Impfstoffes bei...

Quelle: Börse Online RSS Feed

When everything feels like an uphill struggle, just think of the view from the top.vor 2 Stunden
“Bitcoin’s Countdown Has Begun”: Experts Reveal When Quantum Computers Will Finally Shatter Its Legendary Encryptionvor 4 Stunden
We are about to fly soonvor 5 Stunden
We are about to fly soonvor 5 Stunden
We are in the bullish timelinevor 6 Stunden
We are in the bullish timelinevor 6 Stunden
I understand as to why we should hold, but when should we sell?vor 6 Stunden
I understand as to why we should hold, but when should we sell?vor 6 Stunden
Are Bitcoin node developers colluding with miners to raise BTC transaction fees and fill the blocks? Because that's what it looks like...vor 7 Stunden
"Fuck every last crypto idiot on the planet, and fuck every politician who pisses away taxpayer money on unicorn farts and money laundering. Lock the entire lot of them up."vor 10 Stunden